Methods and systems for stratifying patient cancer risk using computational oncology and molecular data
AssigneeTempus AI, Inc.
InventorsTalal Ahmed, Raphael Pelossof, Mark Carty
Life of this patent
Estimating the term…
Loading patent…
AssigneeTempus AI, Inc.
InventorsTalal Ahmed, Raphael Pelossof, Mark Carty
Estimating the term…
A implemented method, computing system and computer-readable medium for stratifying patient cancer risk using molecular data includes receiving molecular data; processing the molecular data using a machine learning model; and generating a matched treatment strategy for the patient based upon the patient's molecular data risk. A computer-implemented method, computing system and computer-readable medium for training a machine learning model to stratify patient cancer risk using molecular data includes receiving a patient training dataset, and a reference training dataset; selecting a cohort of patients; selecting a small subset of genes using univariate selection; generating a corrected reference training dataset; selecting a smaller subset of genes using multivariate selection; training a survival model; and (g) selecting a decision threshold to identify a patient population.
A computer-implemented method for stratifying patient cancer risk using molecular data, comprising:
A computing system, comprising:
A computer-readable medium having stored thereon computer-executable instructions that, when executed by one or more processors, cause a computer to:
Dependencies are inferred from the claim text.